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ABSTRACT 
 
JOЁLLE C. FERRON: PSYCHOLOGICAL MECHANISMS TO TREATMENT 
ADHERENCE AMONG PEOPLE WITH SEVERE MENTAL ILLNESS: VALIDATING 
TREATMENT MOTIVATION AND WORKING ALLIANCE MEASURES 
 
(Under the direction of Kim Strom-Gottfried) 
 
 Working alliance and treatment motivation are important indicators for social work 
clinicians to assess in the course of their practice with individuals with severe mental illness. 
Measures of treatment motivation have yet to be validated for this population, and measures 
of working alliance need further confirmatory work. This study further evaluated the 
Treatment Motivation Questionnaire (TMQ) among people with severe mental illness and 
used confirmatory factor analysis to test the factor structure of the truncated Working 
Alliance Inventory short form (WAI- s) among people with severe mental illness and their 
clinicians. Furthermore, the predictive validity of the TMQ and WAI short form was tested 
by relating these psychological constructs to treatment adherence.  
 Results show that the TMQ had additional subscales of external motivation, which 
further supports Self Determination Theory. The truncated WAI short forms for clinicians 
and consumers were modestly supported, although a second-order confirmatory analysis was 
confirmed. Lastly, the WAI was minimally related to treatment adherence, and the TMQ was 
not predictive of treatment adherence.  
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CHAPTER 1 
 
INTRODUCTION 
 
Empirical evidence shows that individuals with severe mental illness (SMI) 
experience better functioning and reduced symptoms if they follow recommended 
psychiatric treatment (Kampman & Lehtinen, 1999; Thornley & Adams, 1998). 
However, many consumers with SMI do not fully engage in their mental health services.  
For example, up to 75% of consumers with SMI fail to adhere to prescribed regimens of 
medications within two years of discharge from a hospital (Olfson et al., 2000; Perkins, 
1999), leading to increased risk of relapse, suicide, violence, and arrest (Fenton & Mc 
Glashan, 1994; Steadman et al., 2001; Young, Spitz, Hillbrand, & Daneri, 1999).  Studies 
have documented the economic burden of treatment nonadherence in SMI (Thieda, 
Beard, Richter, & Kane, 2003), and one study estimated the direct medical costs from 
nonadherence in psychotic disorders at $2.3 billion per year in the United States (Olfson 
et al., 2000).   
Currently, there is limited understanding of the basic mechanisms underlying 
nonadherence in SMI (Fenton & Mc Glashan, 1994; Kampman & Lehtinen, 1999).  
Failure to adhere to treatment regimens in SMI may result from a number of factors, 
including: lack of social support (Olfson et al., 2000); substance-abuse co-morbidity 
(Heyscue, Levin, & Merrick, 1998; Olfson et al., 2000); difficulty affording treatment or 
obtaining
   
 
transportation (Nageotte, Sullivan, Duan, & Camp, 1997); medication-related factors, 
including unwanted side effects (Fenton & Mc Glashan, 1994; Lieberman et al., 2005; 
Naber & Kasper, 2000) and the way medicines are injested (Steadman et al., 2001); lack 
of insight into illness (Lieberman et al., 2005; Nageotte, Sullivan, Duan, & Camp, 1997);  
and greater psychiatric symptom severity (Adams & Scott, 2000a).   
Although various studies have found social and biological barriers to treatment 
adherence, many of the research instruments used to assess adherence-related variables 
have not been adjusted or adapted for use in populations with severe mental illness, 
(SMI), and with the clinicians who treat them.  For example, many measures are overly 
lengthy and use overly complicated language which increases measurement error due to 
the inattention and/or misunderstanding of research participants with SMI (Harris, 
Minassian, & Perry, 2007). However, brief and accurate scoreable measures could help 
clinicians undertake assessments during clinical sessions. Within the consumer/clinician 
dyad, there are some fundamental prerequisites that lead to successful treatment 
outcomes, such as adherence, the presence of shared goals, trust, and motivation (Corriss 
et al., 1999).  
A few studies have shown that consumers who reported a stronger working 
alliance were more likely to comply with medication regimens and to remain in therapy 
(Frank & Gunderson, 1990; Neale & Rosenheck, 1995). One of the most frequently used 
scales to measure therapeutic alliance among people with SMI is the Working Alliance 
Inventory (WAI) (McAbe & Priebe, 2004). The WAI is grounded in Bordin’s 
conceptualization of working alliance, which includes the trust between the consumer and 
clinician (bonds) and working together to obtain similar objectives (goals) (Horvath & 
2 
  3 
Greenberg, 1989).  Although the WAI long-form has been validated within this 
population, the WAI short-form, a shorter and easier version of the WAI, needs further 
confirmatory scale development (Andrusyna, Tang, DeRubeis, & Luborsky, 2001). Also, 
due to the high correlation between the two factors (bond and goals), a second order CFA 
is needed to assess the fit of the overarching working alliance construct. 
Whereas some previous studies have examined how the therapeutic relationship 
affects treatment adherence in medical patients, no research has systematically explored 
the relationship between treatment motivation and adherence among people with SMI. 
Research in other areas of behavioral medicine has consistently shown that “internalized 
motivation” is associated with greater treatment adherence, for example, in patients with 
diabetes, obesity, alcohol, and nicotine addiction  (Ryan, Plant, & O'Malley, 1995; 
Williams & Deci, 2001; Williams, Grow, Freedman, Ryan, & Deci, 1996; Williams, 
McGregor, Zeldman, Freedman, & Deci, 2004; Williams, Rodin, Ryan, Grolnick, & 
Deci, 1998a, , 1998b).  Furthermore, the psychometric properties of treatment motivation 
scales for people with severe mental illness are unknown. 
 The following studies aim to address these challenges, exploring the validity and 
reliability of two measures with utility for people with severe mental illness. A strong 
working alliance and consumer motivation to attend treatment are essential for positive 
outcomes. However, until instruments are validated to measure constructs such as 
motivation and trust in SMI populations, efforts to create a strong evidence on adherence 
outcomes will be hampered. Once the scales have been psychometrically assessed, the 
predictive validity of the scales can be tested in order to assess the links between 
psychological mechanisms and adherence in this population. 
  4 
Research questions 
First paper: A conceptually-based scale to measure consumers’ motivation for 
attending mental health services 
1) Does the Treatment Motivation Questionnaire (TMQ) maintain the previously 
tested factor structure when applied to persons with severe and persistent mental 
illness?  
2) Are the factors internally reliable?  
Second paper: Confirming the factor structure of the Working Alliance Inventory 
among consumers with severe mental illness and their clinicians. 
1) Does the shortened form of the Working Alliance Inventory (WAI) for 
clinicians and consumers maintain the factor structures found in previous 
research?  
2) If so, do the two subscales of the WAI support a second order factor structure?  
3) What is the internal reliability of the WAI for case managers and consumers?  
Third paper: Predicting psychosocial treatment attendance: The effects of 
working alliance and treatment motivation on increased adherence. 
1) Does working alliance and treatment motivation have the ability to predict 
attendance of clinical meetings (predictive validity of the WAI – Short form and 
TMQ)?  
2) What factors are the strongest predictors of treatment adherence?  
   
 
CHAPTER 2 
THE INTERNAL RELIABILITY AND FACTOR STRUCTURE OF THE TREATMENT 
MOTIVATION QUESTIONNAIRE AMONG PEOPLE WITH SEVERE MENTAL 
ILLNESS 
Treatment motivation is an informative construct that is often included in studies of 
why consumers comply – or fail to comply – with prescribed therapies for various chronic 
diseases. Specifically, research has shown consistently that “internalized motivation” is 
related to greater treatment adherence in people with diabetes, persons in a weight loss 
program, alcohol treatment, and smoking cessation (Ryan, Plant, & O'Malley, 1995; 
Williams & Deci, 2001; Williams, Grow, Freedman, Ryan, & Deci, 1996; Williams, 
McGregor, Zeldman, Freedman, & Deci, 2004; Williams, Rodin, Ryan, Grolnick, & Deci, 
1998a, , 1998b). A strong evidence base shows that individuals with severe mental illness 
(SMI) experience better functioning and reduced symptoms if they follow recommended 
psychiatric treatment (Kampman & Lehtinen, 1999; Thornley & Adams, 1998). However, 
many consumers with SMI do not fully engage in their mental health services.  For example, 
up to 75% of consumers with SMI fail to adhere to prescribed regimens of medications 
within two years of discharge from a hospital (Olfson et al., 2000; Perkins, 1999), leading to 
increased risk of relapse, suicide, violence, and arrest (Fenton & Mc Glashan, 1994; 
Steadman et al., 2001; Young, Spitz, Hillbrand, & Daneri, 1999). However, valid and reliable 
instruments to measure treatment motivation in this
   
 
population have been lacking. This study develops and tests such a measure by adapting the 
Treatment Motivation Questionnaire (TMQ) (Ryan, Plant, & O'Malley, 1995).  
Understanding and measuring the components of treatment motivation in people with 
severe mental illness are complicated by the features of their psychopathology as well as the 
kinds of interventions they tend to receive.  For example, “negative” psychotic symptoms – 
such as amotivation, flat affect, alogia, and social isolation – are often conflated with lack of 
internalized motivation to attend treatment. Similarly in patients with major mood disorders, 
depressive symptoms can interfere with internalized motivation. People with disabling 
psychiatric disorders may also be subjected to external motivating forces, such as involuntary 
hospitalization, forced administration of medication, and various kinds of “leverage” from 
the legal and social-welfare systems designed to improve their adherence with recommended 
treatment in the community (Monahan et al., 2005).  Experiences with these kinds of 
interventions may influence measurement of the domain of external treatment motivation.  
Numerous studies have examined motivation in people with mental disorders using 
Prochaska and DiClementes’ “stages of change” theory (Carey, Purnine, Maisto, & Carey, 
1999).  However, these studies are somewhat limited by their unidimensional focus on the 
construct of change without examining discrete dimensions of motivation.  Self-
determination theory (SDT) (Deci, 1995) may offer a more useful framework for 
understanding and measuring treatment motivation in people with SMI.  Self-determination 
theory (SDT) is a general theory of human motivation that focuses on the extent to which 
behaviors are volitional – performed by an internally-regulated, subjectively-embraced 
choice over alternatives – rather than being manipulated or coerced by external factors that 
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the person does not control.  In the area of health behaviors, empirical research in SDT has 
demonstrated consistently that these factors are associated with greater adherence, for 
example, better glucose control for patients with diabetes (Williams, Freedman, & Deci, 
1998; Williams, McGregor, Zeldman, Freedman, & Deci, 2004), maintenance with smoking 
cessation (Williams & Deci, 2001), alcohol treatment adherence (Ryan, Plant, & O'Malley, 
1995), and long-term maintenance with weight loss interventions (Williams, Grow, 
Freedman, Ryan, & Deci, 1996).  However, there are no previous SDT-based measures of 
treatment motivation that have been validated for populations with severe mental illness.  In 
this study, we develop and test such a measure using an adapted version of the original TMQ, 
which Ryan and Deci (1985) based explicitly on the conceptual framework of SDT. 
According to the Organistic Integration Theory (OIT), a sub-theory of SDT, intrinsic 
or internal and extrinsic or external motivations exist on a continuum. Indeed, OIT postulates 
that externally-motivated behavior can become increasingly integrated into intrinsically-
motivated behavior over time. In Figure 2.1, the OIT continuum is illustrated. The four 
subtypes of external motivation, termed external regulators, are illustrated. The least self-
determined regulator is termed external regulation, which characterizes behavior that is 
performed only to fulfill an external demand or environmental contingency (Ryan & Deci, 
2002). The second-most restrictive regulator is termed introjected regulation. This form of 
regulation is partially internalized and manifests itself in “should statements.” People 
performing behaviors motivated by introjection do so to avoid feelings of guilt and shame. 
The third external regulator is termed regulation through identification. This form of 
regulation occurs when a person believes in the importance of the behavior in the context of 
their identity. Integrated regulation occurs when a person performs behavior that is in 
  8 
concordance with their goals, values, and identity, but does not enjoy the task or engage in 
the task for the sense of enjoyment, the characteristics that separate this extrinsic regulator 
from intrinsic motivation.  Finally, intrinsic motivation involves engaging in a behavior for 
the inherent satisfaction found in the act. 
The Treatment Motivation Questionnaire-Revised (TMQ) is a 25-item scale that was 
originally designed to measure dimensions of a person’s motivation to enter and remain in 
treatment for alcohol dependence; this includes regulators of motivation and other constructs 
from SDT (Ryan, Plant, & O'Malley, 1995). Specifically, the original TMQ included four 
domains based on SDT: confidence in treatment, help-seeking behaviors, and internal and 
external motivation. These domains were confirmed using principal component analysis.   
   
 
Figure 2.1: Self-Determination Continuum Showing Types of Motivation with their Regulatory Styles, Loci Of 
Causality, and Corresponding Processes  (Ryan & Deci, 2002) 
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Ryan and colleagues’ research on the original TMQ produced some limited evidence 
of the reliability and validity of this measure. Assessment of internal reliability found 
Cronbach’s alphas ranging from .70 to .98. Test-retest reliability confirmed that the simple 
structure found from the first principal component analysis remained the same over time. 
Construct validity was assessed through the relationship between motivation, patient 
involvement, and retention in treatment. The researchers found that greater internal 
motivation related with increased patient involvement and retention for adults with alcohol 
abuse and dependence (Ryan, Plant, & O'Malley, 1995).  The measure has not been validated 
across other treatment populations.  
The current study examines the validity and reliability of the TMQ for people with 
severe mental illness. We conduct an exploratory factor analysis (EFA) in order to closely 
examine the underlying structure of treatment motivation in this population.  After obtaining 
the results of the EFA, we conduct a confirmatory factor analysis (CFA) on these results. We 
address two central questions: 1) Does TMQ exhibit a similar factor structure to the original 
TMQ? 2) Does the instrument provide a valid and reliable measure of treatment motivation 
in people with SMI?
10 
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Method 
Sample selection 
Data for this study come from the baseline interview of a sample enrolled in a 
randomized study of the effectiveness of psychiatric advance directives (J. W. Swanson et 
al., 2006b).  The study’s sample criteria included: (1) age 18-65; (2) chart diagnosis of 
schizophrenia, schizoaffective disorder, other psychotic disorder, or major mood disorder 
with psychotic features; (3) currently receiving community-based treatment provided through 
one of two county-based programs in the north-central region of North Carolina; and (4) able 
to give informed consent to the study. 
Approximately 500 patients from two county-based public mental health systems in 
the north-central region of North Carolina were approached for enrollment in the study.  The 
sample was stratified to obtain approximately 20% of participants following an acute 
inpatient admission; this improved the study’s generalizability to SMI patient populations 
(See Swanson et al, 2006).   
Screening, informed consent, and recruitment. 
Treating clinicians verified that identified patients met study criteria and sought 
patient permission to be contacted by a researcher.  Patients willing to be contacted were 
approached by a research interviewer.  The study protocol was approved by the Duke 
University Medical Center Institutional Review Board (IRB) and by the IRBs of the 
participating programs and hospital.   
Measures 
The original Treatment Motivation Questionnaire developed by Ryan and Deci 
(1985) was adapted for the SMI population. A total of 25 items were included in the new 
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survey. Most items remained the same or were slightly changed. For example, the item, “It 
will be a relief for me to share my concerns with other program participants” was revised to 
read, “It will be a relief for me to share my concerns with others in treatment.”  
The TMQ response categories comprise a seven-point Likert scale, ranging from 1 
(not at all true) to 7 (very true). Table 2.1 presents the mean, standard deviation, skewness 
and kurtosis of each item. As shown in the table, most of the items do not have skewness 
values near to or equal to three. Also, the kurtosis values indicate non-zero values. Thus, 
none of the items were normally distributed.  To compensate for the non-normal distributions 
of the items in the psychometric analyses, the data were transformed using standard 
corrective techniques (see statistical analysis). 
 
Table 2.1: Item Descriptions of Central Tendency   
Items n Mean SD Skewness Kurtosis 
I came for treatment at the clinic because:          
1. My family/friend said I should get some help 464 3.31 2.56 0.44 -1.57 
2. I want to make changes in my life 464 5.95 1.79 -1.79 2.07 
3. My doctor/therapist told me I should be in 
treatment 463 4.88 2.37 -0.66 -1.17 
4. I won't feel good about myself if I don't get help 462 5.37 2.13 -1.09 -0.23 
5. I feel so guilty that I have to do something 462 4.13 2.54 -0.13 -1.69 
If I remain in treatment, it will be because:          
6. I'll get in trouble if I don't 463 3.72 2.56 0.12 -1.72 
7. I'll feel very bad about myself if I don't. 463 4.56 2.41 -0.45 -1.41 
8. I'll feel like a failure if I don't. 462 3.95 2.56 -0.02 -1.72 
9. I think it's the best way to help myself 465 6.24 1.53 -2.37 4.87 
10. I don't really feel like I have a choice 464 4.09 2.6 -0.12 -1.74 
How true is each statement to you.          
11. I was under pressure to come 464 3.2 2.49 0.52 -1.45 
12. I am not sure this treatment will work 459 2.5 2.03 1.03 -0.38 
13. I am interested in getting help 465 6.23 1.5 -2.36 5.01 
14. I am not sure this treatment will help with my 
concerns and difficulties 462 2.7 2.15 0.89 -0.72 
15. I wanted to openly relate to others 460 5.37 2.1 -1.11 -0.15 
16. I want to share some of my concerns and 
feelings with others 463 5.43 2.05 -1.13 -0.06 
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17. Important to work closely with others to solve 
my problems 463 5.52 1.96 -1.24 0.31 
18. I am responsible for this type of treatment 460 5.93 1.76 -1.79 2.12 
19. I doubt that this treatment will solve my 
problems 461 2.38 1.98 1.25 0.18 
20. I look forward to relating to others with similar 
problems 459 5.37 2.09 -1.08 -0.21 
21. I chose this treatment because I think it's an 
opportunity for change 460 5.94 1.76 -1.85 2.39 
22. I am not very confident that I will get results 
from treatment this time 458 2.32 1.96 1.32 0.38 
23. It will be a relief for me to share my concerns 
with others in treatment 456 5.23 2.13 -0.95 -0.48 
24. I accept the fact that I need some help and 
support from others 463 5.91 1.78 -1.79 2.10 
25. I am not confident treatment will work for me 462 2.23 1.75 1.47 1.23 
 
Statistical Analyses 
First, the subsample of individuals completing the entire TMQ was compared to the 
original sample through chisquare and t-tests statistics. Factor solutions were generated using 
exploratory factor analysis (EFA) with the principal factoring solution subtype, the minimal 
residual method (MINRES procedure in LISREL). The minimal residual method relaxes 
typical EFA assumptions about the continuous nature of the items and the latent construct 
through the use of full information maximum likelihood estimators (Joreskog & Moustaki, 
2006). Two solutions were explored: the first selected variables based on eigenvalues 
(greater than one) (Gorsuch, 1983) and the second assumed the original four factors specified 
by Ryan and Deci (1985). Within these factor structures, items that accounted for less than 
35% of the variance on a specific factor were incrementally excluded from the analyses 
(Gorsuch, 1983).  
Although, the literature has shown that classic test theory methods such as 
confirmatory factor analysis confound bias with true mean differences, item response theory 
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(IRT) was not used in this analysis because a non-SMI comparison sample was not available 
(Embretson & Reise, 2000). 
Due to the uncertain validity of the construct, competing factor structures were tested 
through confirmatory factor analysis (CFA). First, due to the non-normal distributions of the 
variables, the seven point Likert response scale was treated as an ordinal scale. Polychoric 
correlations and asymptotic covariances were obtained in PRELIS. Then, a Diagonal 
Weighted Least Squares estimator employed the asymptotic covariance matrix and 
polychoric correlation in order to obtain CFA parameters (Weighted Least Squares methods 
require large sample sizes for complex models) (Kline, 2005). A confirmatory factor analysis 
on the TMQ beginning with a common factor model was performed using LISREL (version 
8.54) and subsequent non-significant pathways were eliminated, producing two solutions. 
Listwise deletion was used to handle missing observations, reducing the total sample from 
469 to 422. Cronbach’s alpha values were used to measure reliability of ordinal variables. 
Non-nested models were tested separately with the Root Mean Squared Error of 
Approximation (RMSEA) and Satorra-Bentler chisquares and then comparatively with 
Akaike’s Information Criterion (AIC). 
 
Results 
Sample 
Due to listwise deletion, the sample was reduced from 469 to 422 participants. For a 
more comprehensive description of the entire sample, see the original Psychiatric Advanced 
Directive intervention paper (J. W. Swanson et al., 2006a). 
There was no difference in mean participant age between the original sample (M = 42 
years, SD = 10.7 years) and the TMQ sample (M = 42.2 years, SD = 10.7 years), t(889) = 
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0.28, p = .78 (two-tailed), d = .72.  There was also no difference between the number of 
males (40%) and females (60%) in the samples X2(1, N = 889) = 0.003, p >.05.  Likewise, 
there were no differences between racial group compositions X2(1, N = 862) = 0.002, p >.05 
with African Americans comprising about 58% of the sample and Caucasians comprising 
39% of the sample.  Forty-six percent of both samples reported never having been married, 
again showing no differences between samples X2(1, N = 891) = 0.007, p >.05.   
Regarding clinical diagnosis, there were also no differences between the original 
sample and the subsample for the TMQ due to listwise deletion X2(1, N = 886) = 0.12, p 
>.05. In the TMQ sample, about 58% of participants had a chart diagnosis of schizophrenia 
or a schizophrenia spectrum disorder, 28% were diagnosed with bipolar disorder, and 13% 
were diagnosed with depression with psychotic features.  Psychiatric symptoms were 
measured with the Brief Psychiatric Rating Scale (BPRS). There was no significant 
difference between the entire sample and the TMQ sub-sample (M = 33, SD = 9.2), t(889) = 
0.65, p = .52 (two-tailed), d = .62.  In relation to functioning in everyday life, in the TMQ 
sub-sample, the mean score on the Global Assessment of Functioning (GAF) scale was 40.0, 
with a standard deviation of 10.03, consistent with moderate functional impairment. There 
was no difference on GAF scores between the sub-sample and the original sample (M = 40, 
SD = 10.03), t(889) = .00, p = 1.00 (two-tailed), d = .68. 
The sample is different from the original sample used by Ryan and Deci (1985), 
which was comprised of individuals in alcohol treatment who were not diagnosed with a 
major mental disorder. 
Exploratory Factor Analyses 
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 Exploratory factor analyses revealed two solutions. However, the substantive 
meaning of one of those factors differs from the original TMQ. The original TMQ had only 
one external motivation domain. In the four-factor solution, introjected regulation (a sub-type 
of external motivation) came to the forefront. (Discussion of the meaning of the factors is 
described in greater detail below.) 
In the four-factor solution shown in Table 2.2, an oblique rotation was used, due to 
the a-priori assumption of related subscales. This solution with promax rotation shows a 
nearly-simple structure. However, the third item, “I feel so guilty that I have to do 
something” loads significantly on the Introjected and Intrinsic Motivation subscales – the 
former a positive and the latter a negative loading. Additionally, in order to obtain this 
solution, several items were eliminated. The questions, “I am looking forward to getting 
some social support,” “Others will be angry with me if I don’t,” “I don’t feel like I have a 
choice about staying in treatment,” and “I wouldn’t be here if I really had a choice” did not 
significantly load on factors in either the four- or five-factor solution (factor loadings were 
below .35). However, the four-factor solution also does not include the items, “My 
family/friends said I should get some help,” “My doctor/therapist said I should get some 
help,” and “I’ll get in trouble if I don’t stay in treatment.” These items become part of the 
introjected and extrinsic motivation in the five-factor model. 
Table 2.2: Exploratory Factor Analysis with Four Factor Solution 
Items 
I came for treatment at the clinic 
because: 
Introjected 
Regulation 
Intrinsic 
Motivation  
Lack of 
Confidence Relatedness H2 
       
I want to make changes in my life 0.27 0.40 0.00 0.10 0.65 
       
I won't feel good about myself if I don't 
get help 0.74 0.19 0.09 -0.04 0.38 
I feel so guilty that I have to do 0.73 -0.37 -0.16 0.05 0.50 
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something 
  
  
   
If I remain in treatment, it will be 
because: 
  
   
    
   
I'll feel very bad about myself if I don't. 0.85 0.16 -0.11 -0.15 0.29 
I'll feel like a failure if I don't. 0.82 0.15 0.06 -0.13 0.32 
I think it's the best way to help myself 0.20 0.68 -0.11 0.03 0.33 
  
 
   
  
 
   
How true is each statement to you.      
I was under pressure to come 0.36 -0.41 0.13 0.23 0.69 
I am not sure this treatment will work 0.07 -0.22 0.58 0.02 0.50 
I am interested in getting help -0.02 0.84 0.03 0.03 0.30 
I am not sure this treatment will help 
with my concerns and difficulties 0.05 0.01 0.77 0 0.41 
I wanted to openly relate to others 0.01 -0.02 0.04 0.83 0.33 
I want to share some of my concerns 
and feelings with others -0.12 0.07 0.04 0.88 0.24 
Important to work closely with others 
to solve my problems -0.04 0.13 -0.05 0.74 0.33 
I am responsible for this type of 
treatment -0.01 0.70 0.05 0.06 0.50 
I doubt that this treatment will solve my 
problems -0.06 0.07 0.85 -0.07 0.31 
I look forward to relating to others with 
similar problems -0.08 0.06 0.01 0.81 0.33 
I chose this treatment because I think 
it's an opportunity for change 0.01 0.58 -0.09 0.26 0.36 
I am not very confident that I will get 
results from treatment this time -0.02 0.01 0.93 0.04 0.17 
It will be a relief for me to share my 
concerns with others in treatment -0.07 -0.05 -0.09 0.90 0.21 
I accept the fact that I need some help 
and support from others 0.15 0.32 0 0.39 0.53 
I am not confident treatment will work 
for me -0.12 -0.19 0.52 -0.20 0.44 
 
 
 As seen in Table 2.3, significant communality scores (H2) of items in the introjected 
motivation subscale explain from 29 to 69 percent of the total variance of the model. 
Additionally, factor weights in boldface type indicate significant loading values. Indeed, 
items on the intrinsic subscale contribute from 30 to 65 percent of the total variance. The 
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communalities on the lack of confidence and relatedness subscales have ranges from 0.17 to 
0.50 and 0.21 to 0.53, respectively. This indicates that the items on the lack of confidence in 
treatment sub-scale do not consistently account for variance.  
 
Table 2.3: Exploratory Factor Analysis with a  Five Factor Solution 
       
 
Items 
External 
Regulation 
Introjected 
Regulation 
Intrinsic 
Motivation 
Lack of 
Confidence Relatedness  H2 
I came for treatment at the 
clinic because:       
1a. My family/friend said I 
should get some help 0.56 -0.08 0.03 0.02 -0.01 0.74 
1b. I want to make changes in 
my life 0.24 0.02 0.71 -0.05 -0.08 0.5 
1c. My doctor/therapist told 
me I should be in treatment 0.64 -0.11 0.36 0 -0.06 0.58 
I won't feel good about myself 
if I don't get help 0.25 0.34 0.31 0.07 0.06 0.52 
I feel so guilty that I have to 
do something 0.16 0.61 0.26 -0.10 -0.01 0.39 
       
If I remain in treatment, it 
will be because:       
I'll get in trouble if I don't 0.24 0.60 -0.31 0.15 0.02 0.50 
I'll feel very bad about myself 
if I don't. -0.11 0.94 0.07 0.08 -0.07 0.19 
I'll feel like a failure if I don't. -0.05 0.85 0.11 -0.10 -0.06 0.28 
I think it's the best way to help 
myself -0.07 0.20 0.66 0.11 0.06 0.33 
I don't really feel like I have a 
choice 0.34 0.33 -0.23 -0.09 0.16 0.59 
       
How true is each statement 
to you.       
I was under pressure to come 0.62 0.02 -0.22 -0.06 0.06 0.51 
I am not sure this treatment 
will work 0.06 0.06 -0.18 -0.59 0.01 0.50 
I am interested in getting help -0.02 -0.05 0.82 0.01 0.04 0.31 
I am not sure this treatment 
will help with my concerns 
and difficulties 0.04 0.03 0.01 -0.77 0.02 0.41 
I wanted to openly relate to 
others 0.11 -0.03 0.02 -0.05 0.80 0.34 
I want to share some of my 
concerns and feelings with 
others 0.03 -0.12 0.08 -0.05 0.86 0.25 
Important to work closely with 
others to solve my problems -0.03 0 0.1 0.03 0.76 0.32 
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I am responsible for this type 
of treatment -0.21 0.08 0.53 -0.02 0.19 0.54 
I doubt that this treatment will 
solve my problems 0.04 -0.06 0.10 -0.85 -0.07 0.30 
I look forward to relating to 
others with similar problems 0.03 -0.06 0.06 -0.02 0.81 0.33 
I chose this treatment because 
I think it's an opportunity for 
change -0.04 -0.02 0.57 0.10 0.27 0.36 
I am not very confident that I 
will get results from treatment 
this time 0.02 0.01 -0.02 -0.92 0.07 0.17 
It will be a relief for me to 
share my concerns with others 
in treatment 0.00 -0.03 -0.09 0.08 0.92 0.20 
I accept the fact that I need 
some help and support from 
others -0.16 0.26 0.2 -0.03 0.49 0.50 
I am not confident treatment 
will work for me -0.17 0.00 -0.20 -0.58 -0.16 0.40 
 
The five-factor solution found that the original extrinsic motivation subscale became 
divided into two forms of extrinsic regulation, namely, introjected regulation (also found in 
the four-factor model) and extrinsic regulation that includes pressure from friends/family and 
doctors/therapists to attend treatment. This additional division of the old extrinsic motivation 
domain provides new and substantive explanatory power. More discussion of the subscales’ 
naming and meaning will be provided in subsequent sections. 
 As seen in Table 2.3, the five-factor solution has simple structure. Items that were 
excluded from the model are shown in italicized and bold print indicating low factor loadings 
across subscales. Additionally, the rotation methods provided in MINRES of promax and 
varimax both produce a solution with one negatively loaded factor. The rotational issue will 
not affect the CFA model, but questions about the validity of this subscale within this 
measurement model should be tested.  
 Similar communality values are shown in the five-factor model. The addition of 
external motivation illustrates that these three items account for 51 to 74 percent of the total 
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explained variance of the model. In Table 2.3, the factor loadings in bold represent 
significant values. 
Near Simple Solution 
The results of the confirmatory factor analysis produced two near-simple solutions. 
As shown in Appendix I, polychoric correlations were produced in order to perform these 
analyses (they are illustrated here for replication purposes). Table 2.1 can be used as a 
reference for the numbers used to represent items in Appendix I. In both the four and five 
factor models, analysis began with a common factor model and non-significant factor 
weights were eliminated from each model in order to produce near simple solutions. 
 The four-factor model had conflicting results. Firstly, the Satorra-Bentler Chi-Square 
was significant (X2=327.69, df=160, p=.0000), indicating a notable difference between the 
data and the model specified. However, the model had excellent Comparative Fit Index (CFI) 
and Goodness of Fit Index (GFI) scores of 0.99 and 0.98, respectively.  The RMSEA was 
adequate at 0.05 with a 90 percent confidence interval of (0.042- 0.057). Additionally, there 
were only 18 standardized residuals (out of 200) greater than 2.58 (about 9%). Thus, the 
overall fit statistics for four-factor near-congeneric model indicate a poor fit.  
In the five-factor model, the model fit was excellent overall. The Satorra-Bentler 
Scaled chi-square test was non-significant, indicating no significant differences between the 
model and the data (X2=223.43, df=218, p=.39). The model had excellent Comparative Fit 
Index (CFI) and Goodness of Fit Index (GFI) scores of 0.96 and 0.97 respectively. The 
overall Root Mean Square Error of Approximation (RMSEA) was .008 with a 90%confident 
interval from (.0-.022), which also indicates an excellent fit for the model. Additionally, there 
were only 33 standardized residuals (out of 264) that were greater than 2.58 (about 12.5%). 
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Thus, the overall fit statistics for the five-factor near-congeneric model indicate an excellent 
fit.  
Because the models are not nested (due to the cross-loadings of the items on different 
factors), the Akaike’s Information Criterion (AIC) was used to aid in the comparison of the 
models (smaller is better). The AIC for the four-factor model is equal to 462.55, and the AIC 
for the five-factor model is equal to 339.43. These results indicate that the five-factor model 
fits the data better. 
Table 2.4 illustrates the factor loadings, standard errors, and squared multiple 
correlation values for each item in the five-factor near-congeneric model. As shown in Table 
2.4, all items loaded positively and significantly on their corresponding factors. It should be 
noted that the analyses of the 25 items of the TMQ are data driven and thus exploratory in 
nature. Nevertheless, these analyses provide compelling evidence that the five-factor 
structure best explains the observed relationships between the 25 TMQ items. 
Table 2.4: Five Factor Model Confirmatory Model  
 
Items 
External 
Regulation 
Intrinsic 
Regulation 
Lack of 
Confidence 
Introjected 
Motivation Relatedness R2 
 
Regression 
Coefficient 
(standard 
error) 
Regression 
Coefficient 
(standard 
error) 
Regression 
Coefficient 
(standard 
error) 
Regression 
Coefficient 
(standard 
error) 
Regression 
Coefficient 
(standard 
error)  
I came for treatment at 
the clinic because:       
My family/friend said I 
should get some help 0.98 (0.23)     0.22 
I want to make changes in 
my life  0.74 (0.04)    0.32 
My doctor/therapist told 
me I should be in 
treatment 1     0.23 
I won't feel good about 
myself if I don't get help    0.95 (0.06)  0.68 
        
If I remain in treatment, 
it will be because:       
I'll get in trouble if I don't 0.97 (0.26)   0.29 (0.08)  0.4 
I'll feel very bad about    1  0.76 
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myself if I don't. 
I'll feel like a failure if I 
don't.    0.97 (0.06)  0.71 
I think it's the best way to 
help myself  1.08 (0.04)    0.68 
        
How true is each 
statement to you.       
I was under pressure to 
come 1.23 (0.4)     0.35 
I am not sure this 
treatment will work   0.93 (0.04)   0.53 
I am interested in getting 
help  1    0.59 
I am not sure this 
treatment will help with 
my concerns and 
difficulties   0.86 (0.04)   0.45 
I wanted to openly relate 
to others     0.88 (0.03) 0.6 
I want to share some of 
my concerns and feelings 
with others     0.97 (0.04) 0.73 
Important to work closely 
with others to solve my 
problems     1.00 (0.03) 0.77 
I am responsible for this 
type of treatment  0.89 (0.04)    0.46 
I doubt that this treatment 
will solve my problems 
  1.00 (0.03)   0.6 
I look forward to relating 
to others with similar 
problems     0.94 (0.03) 0.68 
I chose this treatment 
because I think it's an 
opportunity for change 
 1.1 (0.05)    0.71 
I am not very confident 
that I will get results from 
treatment this time   1   0.6 
It will be a relief for me to 
share my concerns with 
others in treatment     1 0.77 
I accept the fact that I 
need some help and 
support from others  0.47 (0.08)   0.42 (0.09) 0.44 
I am not confident 
treatment will work for 
me   1.09 (0.04)   0.72 
 
Reliability of the TMQ Subscales 
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 The overall reliability of the TMQ subscales is adequate. The lowest reliability 
coefficient is for the subscale of external regulation, which has an unacceptable standardized 
Cronbach’s alpha (α=0.51). The subscales for intrinsic motivation (α=0.78), lack of 
confidence in treatment (α=0.82), introjected regulation (α=0.73), and relatedness motivation 
(α=0.87) had subscales reliability scores within a respectable range of values (DeVellis, 
2003).  
Substantive Meaning of Factors 
 Due to the exploratory nature of the analysis, the factors differ somewhat from the 
original TMQ scale, particularly in the addition of the introjected motivation subscale. The 
additional factor is a result of a sub-factor of the original external motivation domain. 
Beyond the statistical criteria for the five factor model, the additional factor, introjected 
motivation, is a composite of items characterized by guilt and “should” statements. Introjects 
have been described as external or group values that the individual has not fully recognized, 
embraced, or integrated into the self (Deci, 1995). Items such as, “I'll feel like a failure if I 
don't. . .” are laden with feelings of guilt and negative affect. Avoiding feelings of shame and 
guilt are the primary motivators in this domain. Theory in this area suggests that beyond 
avoiding negative affect, following introjected motivation enhances ego functioning. Thus, 
introjected regulations (or motivations) can reduce self-esteem (Ryan & Deci, 2002). 
 The introjected regulation items differ from the external regulation items by the type 
of statement and the source of the motivation. External motivators are reinforced by a source 
outside of the individual. Items such as, “My friend/family told me I should be in treatment” 
indicates motivation deriving from an outside source, whereas the introjected motivation is 
an internal voice derived from an external place. The other external motivation items are: 
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“My family/friends told me I should get some help” and “I was under pressure to come.” 
However, one of the items of this scale is also loaded on the introjected domain. The item, 
“I’ll get in trouble if I don’t” loads on both the introjected and external motivation scales. In 
this case, the item’s wording does not clarify whether getting in trouble is a real external 
motivator, a perceived external motivator, or introjected motivation. 
 The three other subscales are similar to Deci and Ryans’ original scale. Lack of 
confidence (LOC) in treatment is another subscale, which is characterized by a consumers’ 
non-belief or ambivalence in treatment. An example of a LOC item is, “I am not sure this 
treatment will help with my concerns and difficulties” Individuals with high scores in this 
area have concern and doubt about the treatment they are receiving. 
  Relatedness or interpersonal help seeking behaviors is another subscale from the 
original TMQ. This subscale is characterized by statements that illustrate the importance of 
communication with fellow consumers or patients during the treatment process. Statements 
such as, “It is important to work closely with others to solve my problems” are characteristic 
of this domain.  
Lastly, intrinsic or internal motivation is a subscale defined as, “engaging in an 
activity for the pleasure and satisfaction inherent in that activity” (Ryan & Deci, 2002). The 
items of this subscale are much like the original subscale. They are characterized by items 
such as, “I remain in treatment because I think it's the best way to help myself.” Items in this 
domain illustrate the individual’s internalized motivation and drive for therapeutic treatment. 
 
Discussion 
  25 
 The original scale by Ryan and Deci (1985) was only partially confirmed. However, 
revisiting the TMQ lends further support for the current conceptual framework of self-
determination theory (SDT) and organismic integration theory (OIT).  Specifically, external 
motivation is an overarching construct that comprises several sub-dimensions or regulators of 
emotion: external, introjected, indentified, and integrated. The CFA of the TMQ substantiates 
two of these four regulatory sub-dimensions -- external and introjected motivation. 
Importantly, these results indicate that different types of external motivators are at work in 
motivating treatment participation by people with severe and persistent mental illness. Due to 
the largely coercive nature of many treatment modalities for this population, the TMQ may 
be helpful in assessing externally motivating sub-dimensions. However, future work should 
develop more questions relating to the sub-dimensions of identified and integrated 
motivation.  
In addition to adding sub-dimensional items and factors to fit all of the external 
motivation categories in SDT, two items that loaded on two sub-scales need confirmatory 
validation or rewording. The item, “I'll get in trouble if I don't,” is significantly related to 
external motivation and introjected motivation. This dual loading indicates an ambiguous 
question that could indicate being punished by an external source or feeling the fear that the 
person may get into trouble. Wording of this item could be improved by making it more 
specific to the situation, for example, “The mental health center will refuse to help me if I 
don’t.” Likewise, the item, “I accept the fact that I need some help and support from others” 
loaded on instrinsic motivation and relatedness subscales. This is a double- barreled question 
that could be further separated into, “I accept the fact that I need some help,” which appears 
to be an intrinsic motivation item, and “I accept the fact that I need some support,” which 
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appears to be a relatedness item. These findings illustrate the additional need to confirm this 
factor pattern while testing some new questions in order to strengthen the TMQ.  
Although the testing of the TMQ was not definitive, the methods employed in this 
study were more accurate than previous research in verifying the measurement structure of 
this instrument, specifically, by compensated for non-normally distributed data with an 
asymptotic covariance structure and polychoric correlation. Additionally, the confirmatory 
factor analysis method produced an overall fit statistic for assessing the strength of the 
model. Although these methods were partially data driven, the substantive meanings behind 
the factors demonstrate construct validity in the TMQ. Additionally, the Cronbach’s alpha 
statistic used to measure internal consistency may not be as robust with ordinal data. 
However, currently there are no measurements in the field that measure internal consistency 
for ordinal data, particularly with the assumption that measurement points within the scale 
may not have equal distances from each other.  
The primary limitations of the current scale development is that replication of the 
current findings are needed before the scale can be reliably used within the SMI population. 
Firstly, additional items need to be generated for the external motivation subscale. Secondly, 
confirmatory factor analysis needs to be performed in order to further validate the scale and 
test whether or not a congeneric solution can be obtained.  In addition, the predictive validity 
of the scale should be tested in order to replicate studies in parallel areas of research that 
have found intrinsic motivation to be a predictor of medication adherence. 
 Further, future research on the TMQ should assess the instrument’s time-invariant 
properties. The time variable is relevant to this population because persons with chronic 
illnesses may need sustained internal motivation to remain in treatment over time. In 
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contrast, other behaviors may require internal motivation at the beginning of treatment, but 
less so over time. In addition to time invariance, group invariance would also be an important 
property to test. Further work should be done to examine the differences across diagnoses. 
This could contribute to clinical assessment, for example, in better distinguishing between 
the lack of intrinsic treatment motivation per se and the negative symptoms of schizophrenia.  
Clinical Implications 
The current analysis confirms the applicability of the SDT conceptual framework for 
understanding treatment participation (or lack of participation) among people with severe 
mental illness. Although the literature on treatment adherence among SMI individuals often 
highlights the role of coercion and external motivators, little has been done to explore the 
different types of external regulators or motivations that may actually drive or inhibit 
treatment engagement in this population. Knowing more about the specific types of 
motivation that support long-term treatment adherence in these individuals would help 
unpack treatment resistance for clinicians and aid clinicians in their efforts to engage patients 
in beneficial therapies over time.  
 
   
 
CHAPTER 3 
A CONFIRMATORY FACTOR ANALYSIS OF THE WORKING ALLIANCE INVENTORY 
SHORT FORM AMONG PEOPLE WITH SEVERE MENTAL ILLNESS AND THEIR 
CLINICIANS 
 
The current mental health care system relies heavily on case management services for 
people with severe mental illness (SMI).  The working alliance between case managers and 
service users is an essential factor in successfully providing treatment and resources (Hopkins & 
Ramsundar, 2006). Although the importance of working alliance as a concept was first 
highlighted by Freud in the context of psychoanalysis, researchers have struggled to define and 
create ‘theory free’ constructs to measure working alliance. One such construct is the Working 
Alliance Inventory (WAI) created by Horvath and Greenberg (1989) based on Bordin’s (1979) 
definition of working alliance. Bordin (1979) defined working alliance as the shared goals, tasks, 
and bond experienced by the consumer and therapist within the treatment relationship.  
In general, working alliance has been consistently related to numerous positive therapy 
outcomes across treatment and theoretical approaches (Horvath & Greenberg, 1989; Martin, 
Garske, & Davis, 2000).  Moreover, different theoretical clinical approaches have not been 
shown to have significantly different effect sizes (Ahn & Wampold, 2001; Stiles, Shapiro, & 
Elliott, 1986); because of this finding, researchers are turning to process related variables across 
clinical and theoretical approaches in order to find predictors of positive outcomes. For example, 
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findings from the national study on depression suggest that working alliance has a significant 
positive effect on therapy and pharmacotherapy (Krupnick et al., 1996). Other studies have found 
that working alliance is related to positive outcomes across differing clinical populations, such as 
people with alcohol problems (Dearing, Barrick, Dermen, & Walitzer, 2005), partner violent 
men (Taft, Murphy, Musser, & Remington, 2004), and older adults (Hyer, Kramer, & Sohnle, 
2004).  
Specific to the treatment of individuals with SMI, studies across treatment types report 
increased working alliance related to positive outcomes. For example, one study found that a 
greater working alliance between inpatient staff and consumers related to less time in the hospital 
(Johansson & Eklund, 2006). Similarly, studies in rehabilitation treatment for individuals with 
SMI found that a greater working alliance related to better consistency in consumers’ work and 
better overall goal attainment within therapy  (Gehrs & Goering, 1994; Lieberman et al., 2005; 
O'Donnell et al., 2003). Also, in outpatient therapy, studies found that a greater working alliance 
related to better treatment attendance, completion of homework, a decrease in symptom severity, 
better global functioning, and increased community living skills (Dunn, Morrison, & Bentall, 
2006; Neale & Rosenheck, 1995; Pyszczynski, Greenberg, & Solomon, 2000).  
 Due to the significance of the working alliance across therapies, there has been 
substantial research that supports the reliability and validity of numerous measures of working 
alliance (Fenton & Mc Glashan, 1994). The present study focused on the Working Alliance 
Inventory (WAI), which was developed from Bordin’s tripartite model. The WAI offers a 
construct that can be used across therapies and disciplines (Howgego, Yellowlees, Owen, 
Meldrum, & Dark, 2003). Extensive psychometric research has been performed to substantiate 
the reliability and validity of the WAI in the original long form (Hanson, Curry, & Bandalos, 
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2002; Horvath & Greenberg, 1989; Tracey & Kokotovic, 1989), and more recently, research on 
reliability and validity of the WAI short form supports the interchangability of the long and short 
forms (Busseri & Tyler, 2003; Hatcher & Gillaspy, 2006). Overall, the WAI inventory has 
proven reliable and valid in the general psychotherapy population. However, there is a dearth of 
research on the WAI within people with SMI. 
A few studies have explored the psychometric properties of the WAI for people with SMI 
(Bale, Catty, Watt, Greenwood, & Burns, 2006; Gehrs & Goering, 1994; Goldberg, Rollins, & 
McNary, 2004). Within these studies, Bale et al (2006) reviewed the construct validity of the 
WAI long form through use of the Helping Alliance Questionnaire (HAQ), which was created 
for use within people with SMI. They found that the consumer versions of HAQ and WAI were 
highly correlated, but that the WAI clinician form was weakly correlated with both the consumer 
scales (Bale, Catty, Watt, Greenwood, & Burns, 2006). In contrast, another study of the WAI 
long form found the WAI consumer and therapist version to be highly correlated (Gehrs & 
Goering, 1994). Considering the contradictory findings of these studies, it is likely that some of 
the findings are affected by sample selection bias or other factors that are not measured. The 
final study aimed to test the reliability and internal consistency of the WAI short form within 
people with SMI (Goldberg, Rollins, & McNary, 2004). This study found fair to moderate test-
retest reliability and internal consistency. They also found weaker correlations between working 
alliance scores for consumers and clinicians and attributed this difference to distinctly different 
perceptions of the relationship within the therapeutic dyad. The shortcomings of this study are 
that they had a small sample size (n= 64) and did not perform a factor analysis. On the whole, 
some preliminary measurement diagnostics on the WAI short form have appeared in the 
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literature, however, more psychometric studies are needed in order to confirm and support the 
structure of this instrument for people with SMI.    
The primary aim of the current study is to test the factor structure of the WAI short form 
for individuals with SMI and their case managers or primary therapists. If the Working Alliance 
Inventory (WAI) short form maintains the factor structure found in previous research, do the two 
subscales of the WAI support a second order factor structure? What is the internal reliability of 
the WAI short form for case managers and consumers? Is there agreement between the case 
managers’ and consumers’ views of the working alliance? Does this relationship depend on the 
duration of the therapeutic relationship? 
Method 
Sample selection 
Data for this study come from the baseline interview of a sample enrolled in a 
randomized study of the effectiveness of psychiatric advance directives (J. W. Swanson et al., 
2006b).  As described in Chapter II, the study’s sample criteria included: age 18-65; chart 
diagnosis of schizophrenia, schizoaffective disorder, other psychotic disorder, or major mood 
disorder with psychotic features; currently receiving community-based treatment provided 
through one of two county-based programs in the north-central region of North Carolina; and 
able to give informed consent to the study. 
Treating clinicians verified that identified patients met study criteria and sought patient 
permission to be contacted by a researcher.  Patients willing to be contacted were approached by 
a research interviewer.   
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Consumer Characteristics. 
The mean participant age was 42 years (standard deviation=10.7 years).  The sample was 
predominantly female (60%) and African American (58%). Thirty-nine percent of the sample 
was white, and 3% were from other racial backgrounds.  Forty-six percent reported never having 
been married.  Thirty-four percent of the sample had a high school education or equivalent. At 
the time of enrollment, 55% of participants were living in their own home or apartment.    
Regarding clinical diagnosis, 59% of participants had a chart diagnosis of schizophrenia 
or a schizophrenia spectrum disorder, 27% were diagnosed with bipolar disorder, and 14% were 
diagnosed with depression with psychotic features.  Approximately 49% had reported some 
symptoms or complaints of a substance use disorder.  Psychiatric symptoms were measured with 
the Brief Psychiatric Rating Scale (BPRS) and the mean score on the BPRS was 33.6, with a 
standard deviation of 9.2, indicating a moderate level of symptomatology.  In relation to 
functioning in everyday life, the mean score on the Global Assessment of Functioning (GAF) 
scale was 40.0, with a standard deviation of 10.3, consistent with moderate functional 
impairment. 
Regarding mental health services utilization, 72% of participants reported at least one 
outpatient visit during the month prior to baseline, while 35% had been hospitalized for 
psychiatric disorder in the previous six months. 
Coercive treatment experiences were commonly reported:  Sixty-eight percent of 
participants reported lifetime experiences of involuntary intervention surrounding a past 
hospitalization, such as being handcuffed by police for transport to the hospital, receiving forced 
medication, or being subjected to physical restraints and seclusion.   However, hospitalization 
was not uniformly viewed as an unwanted event; 38% of the sample reported experiences in 
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which they felt the need to be hospitalized, but were not admitted.  For a more comprehensive 
description of this sample, see the original Psychiatric Advanced Directive intervention paper (J. 
W. Swanson et al., 2006a). 
Forty-eight percent of the sample reported past experiences of leveraged community 
treatment (outpatient commitment, criminal justice sanctions, money, or housing conditioned on 
outpatient treatment participation); 24% were currently under one or more of these types of 
leverages.   
Clinician Characteristics. 
Of the clinician sample, clinicians were on average slightly over 40 years old (41.3, S.D. 
13.74), and over a quarter of the clinicians were male (26.9 percent).  Nearly half the clinicians 
were white (46.2 percent), with the majority of the remainder black/African-American (44.9 
percent).  Less than half of the sample had a bachelor’s degree or less (42.3 percent).  Slightly 
over 15% of the sample had a master’s in social work (19.74 percent) and about 10% reported 
having some other master’s degree (9.73 percent). Nearly 20% of the sample had a nursing 
degree (19.46 percent). Clinicians were on average quite experienced, reporting over 11 years of 
mental health services experience (12.0, S.D. 8.78).  Their reported caseload size was large, with 
an average of 73.7 (S.D. 94.66).  It should be noted, however, that the range of caseload size 
varied dramatically, from a low of 7 to a high of 450. Due to listwise deletion, the clinician 
sample was reduced by 2 participants lowering the number of clinicians from 79 to 77. 
Measures 
Working Alliance Inventory (WAI). 
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Working alliance was assessed with the short form of the Working Alliance Inventory 
(WAI) adapted for use with SMI individuals and their mental health clinicians (Horvath & 
Greenberg, 1989; Neale & Rosenheck, 1995). Both the consumer and clinician forms of the WAI 
measure two domains. The WAI measures the degree to which the therapist and consumer 
perceive a bond and shared goals in their working relationship. The two scales for therapist and 
consumer share parallel forms. For example, under the shared goal subscale, the consumer is 
asked to rate the statement, “My clinician perceives accurately what my goals are;” the clinician 
is asked to rate the statement, “The client and I have a common perception of his/her goals.” The 
WAI response categories comprise a five-point Likert scale, ranging from 1 (strongly agree) to 5 
(strongly disagree). 
Analysis Plan 
Of the 469 consumers and 79 clinicians interviewed, all of the consumers completed the 
WAI, but not all of the clinicians for those consumers could be interviewed. Due to this, only 
361 clinician responses were used in this analysis (77 clinician responses), but the total 469 
sample of consumers was used. 
The Working Alliance Inventory short forms for case managers and consumers were 
analyzed using confirmatory factor analysis (CFA) with the factor structure specified in the 
original study (Horvath & Greenberg, 1989). A CFA requires normal distribution of the scale 
items (Bollen, 1989; Gorsuch, 1983; Kline, 2005).  Due to the non-normal distributions of the 
variables, the Likert response scale were treated as an ordinal scale and polychoric correlations 
and asymptotic covariances were obtained in PRELIS in order to account for the ordinal scale 
assumptions. The ordinal response assumptions also required the use of a robust estimator, so the 
Diagonal Weighted Least Squares method were used to estimate CFA parameters (Kline, 2005). 
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A confirmatory factor analysis was performed using the LISREL program (version 8.54) and the 
factor structure was based on previous solutions confirmed with other populations (Horvath & 
Greenberg, 1989). Listwise deletion was used to handle missing observations. Model fit was 
evaluated with Root Mean Squared Error of Approximation (RMSEA) and Satorra-Bentler 
chisquares along with other fit indexes. Then, a higher order factor analysis was performed on 
the subscales of bond and shared goals for the consumer and clinician WAI measures in order to 
test the validity of the larger construct of working alliance. 
Cronbach’s alpha values were used to measure reliability of the factors within the 
consumer and case manager version of the scale. Further, correlations between the case manager 
and consumer factors were performed after stratifying the dyads by the median time of their 
working relationship. This was done in order to assess the influence of relational time on the 
perception of working alliance.  
 
Results 
Distributions of WAI-short form items 
 The distributions of the observed responses for both the WAI short forms are presented in 
Table 3.1. Bollen (1989) notes that tests of normality are essential to detecting violations of the 
generalized estimators used in confirmatory factor analysis. Specifically, when measures of 
skewness and kurtosis are not equal to 0 and 3, respectively, using the data with maximum 
likelihood estimators may produce erroneous results. As illustrated in Table 3.1, skewness values 
range from somewhat close to zero (0.62) to over one point away from zero (1.27), which 
displays positive skewness. Additionally, the kurtosis values range from -0.15 to 2.07 indicating 
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that the distributions have much thinner tails than a normal distribution. Correlation matrices for 
the WAI consumer and clinician are located in Appendices II and III.
   
 
 
 
Table 3.1: Distributions of Working Alliance Inventory - Short Form items 
Working Alliance Inventory - Short Form         
 Consumer  Clinician 
Items n Mean SD Skewness Kurtosis n Mean SD Skewness Kurtosis 
Have a common perception of the 
client's goals. 469 2.04 1.02 0.93 0.30 378 2.14 0.88 1.08 1.26 
The current goals of the work are 
important to client. 469 1.83 0.87 1.27 2.07 375 3.93 0.89 -1.06 1.15 
Have established a good 
understanding of the kinds of 
changes that would be good for 
client. 469 2.07 0.98 0.85 0.33 378 2.21 0.87 0.78 0.40 
Are working toward mutually 
agreed upon goals. 469 2.06 0.94 0.87 0.47 377 2.11 0.84 0.97 1.08 
Feel confident in clinician's 
ability to help client. 469 1.92 0.92 1.08 1.08 381 4.09 0.71 -0.70 0.90 
The relationship is important to 
the client. 469 1.94 0.90 0.98 0.87 371 2.11 0.86 0.85 0.85 
The client has trust in clinician. 469 2.05 0.95 0.86 0.52 368 1.98 0.73 0.88 2.07 
Have established a strong 
working alliance and rapport. 469 1.97 0.98 1.17 1.31 374 2.21 0.95 0.62 -0.15 
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First order factor structure. 
 The CFA results indicated that the consumer model had an adequate fit (SBX2(19) = 
41.60, p =.002; CFI = 1.00; GFI = 1.00; RMSEA (90% C. I.) = 0.05 (0.029 - 0.071); RMR = 
0.024; SBX2/df = 2.19). As shown in Table 3.2, all factor loadings were statistically 
significant and support previous factor structures. Further, the two consumer WAI factors 
had a high positive correlation (r=.82, p<.01), indicating a second order factor analysis may 
fit the data. 
The CFA results indicated that the clinician model had an adequate fit (SBX2(19) = 
32.22, p = .03; CFI = 1.00; GFI = 1.00; RMSEA (90% C. I.) = 0.04 (0.004 - 0.09); RMR = 
0.042; SBX2/df = 1.70). As shown in Table 3.2, all factor loadings were statistically 
significant. Further, the two consumer WAI factors had a high positive correlation (r=.69, 
p<.01), indicating a second order factor analysis may fit the data. 
Table 3.2: Confirmatory Factor Analysis Results of the WAI- short form 
Working Alliance Inventory Short Form     
  Consumer Clinician 
Items Goal Bond 
R 
squared Goal Bond 
R 
squared 
 
Regression 
Coefficient 
(standard 
error) 
Regression 
Coefficient 
(standard 
error) 
 
Regression 
Coefficient 
(standard 
error) 
Regression 
Coefficient 
(standard 
error) 
 
Have a common perception of 
the goals. 0.97 (0.04)   0.71 0.96 (0.06)   0.75 
The current goals of the work 
are important 1.00 (0.04)   0.75 0.69 (0.08)   0.39 
Have established a good 
understanding of the kinds of 
changes that would be good 1.02 (0.03)   0.78 1.00   0.81 
Are working toward mutually 
agreed upon goals. 1.00   0.76 0.99 (0.05)   0.8 
Feel confident in ability to help 
client.   1.05 (0.03) 0.87   0.82 (0.04) 0.57 
The relationship is important   1.02 (0.03) 0.81   0.95 (0.03) 0.77 
The client has trust in clinician.   1.00 0.78   1.00 0.85 
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Have established a strong 
working alliance and rapport.   1.02 (0.03) 0.82   1.02 (0.03) 0.89 
 
Second order factor structure. 
 Results of the second order CFA of the consumer WAI indicate an excellent fit of the 
model (SBX2(18) = 25.86, p = .10; CFI = 1.00; RMSEA (90% C. I.) = 0.03 (0.0 - 0.06); RMR 
= 0.024; SBX2/df = 1.44). Likewise, the results of the clinician CFA produce an excellent fit 
(SBX2(18) = 20.72, p = .29;CFI = 1.00; RMSEA (90% C. I.) = 0.02 (0.0 - 0.05); RMR = 
0.042; SBX2/df = 1.15). 
Internal reliability. 
 The internal reliability (Cronbach’s alpha) of the consumer version of the Goal 
subscale was .89 and the Bond subscale was .92, both indicating a high degree of internal 
reliability. The total scale score was .94, which indicates a high degree of internal 
consistency but also that the scale items may be redundant (DeVellis, 2003). Additionally, 
the internal reliability (Cronbach’s alpha) of the clinician Goal subscale was .85 and the 
Bond subscale was .87, indicating that both had excellent internal reliability. Further 
supporting the good internal reliability, the total score alpha was .91.   
Congruence. 
 The congruence between clinician and consumer ratings of working alliance for the 
entire sample on the Goal subscale was negligibly correlated, r(n=376)= .24, p<.01, and the 
Bond subscale was also negligibly correlated, r(n=381)= .27, p<.01. When the sample was 
divided at the median duration of the working alliance (m = 12 months), the consumer and 
clinician Goal subscales correlation increased to a low degree of correlation r(n=181) =.36, 
p<.01, for working relationships longer than one year and no correlation for relationships 
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shorter than one year, r(n=190) =.18, p<.01,. Similarly, the Bond subscales were minimally 
correlated in relationships older than one year, r(n=181) =.39, p<.01, and had a negligible 
correlation for relationships lasting under one year, r(n=195) =.19, p<.01.  
Discussion 
In this study, the WAI - Short form was tested within a sample with SMI and their 
clinicians. Our overall finding provides moderate support for the original factor structure and 
strong support for a higher-order model for this population. The excellent model fit for both 
consumer and clinician second-order structure indicates that the two subscales of Bond and 
Goals in the working alliance relate to the larger construct of working alliance; thus, 
summing the subscales to create a total score is appropriate.    
Further, psychometric analyses indicate that the Goal and Bond subscales for both the 
consumer and the clinician had excellent internal reliability. Indeed, the internal reliability of 
the total score of the consumer version illustrate that the items may be redundant and that 
item reduction may help add to the parsimony of this scale. Internal reliability results were 
similar to results found in the original WAI-S research performed with another population 
(Hatcher & Gillaspy, 2006).  
 The correlations or lack of correlations between the consumer and clinician version 
of the WAI have been interpreted by some as a threat to the construct validity of the scale. 
On the contrary, the results of this study indicate that the congruence of consumer and 
clinician scores on working alliance are related to other factors, particularly the length of 
time the dyad has worked together. There could be several other mediators and moderators 
affecting the working relationship. For example, the consumers’ relational capacity or 
blunted affect may inhibit their ability to relate to a clinician; likewise, a clinician may lack 
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emotional expression, fail to convey commitment to the success of the working relationship, 
or have a large caseload that does not facilitate close working relationships with consumers. 
Limitations 
 This study is limited in several ways. The current study aims to confirm the factor 
structures of the original WAI – Short form base in Bordin’s tripartite theory, however, one 
of the subscales – the task subscale – was omitted from the study. The task subscale is 
composed of items like, “My therapist and I agree about the things I will need to do in 
therapy to help improve my situation.” Also, the nesting of the clinician subscale was not 
accounted for in this study (the nesting of consumers within clinician, i.e. clinicians reporting 
for numerous consumers may create a restricted range of variance and thus may produce 
smaller standard errors). Although this subscale was excluded from the current study, other 
published factor analyses of this scale indicate a one-factor solution, suggesting that the 
working alliance subscales are not conceptually different from one another (i.e. the subscales 
may be redundant) (Hatcher & Barends, 1996; Salvio, Beutler, Wood, & Engle, 1992).  
Conclusions 
 In summary, the confirmatory factor analyses and psychometric testing of the 
consumer and clinician WAI short form produced several key findings. First, the factor 
structure of the original version was only moderately supported, whereas a second order 
structure was supported. Second, the internal reliability of the scales and subscales was very 
high, which further supports the use of the subscales and the total score within these 
populations. Finally, this study illustrates that the construct of working alliance for 
consumers and clinicians is not necessarily correlated if the duration of the working alliance 
does not support the time for alliance to develop. Overall, the WAI short form proves to be a 
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reliable and brief scale that could easily be administered by clinicians in order to better 
monitor their practices.  
   
 
CHAPTER 4 
  
PREDICTING PSYCHOSOCIAL TREATMENT ATTENDANCE AND 
ADHERENCE: THE USE OF WORKING ALLIANCE AND TREATMENT MOTIVATIONS 
AS MECHANISMS TO INCREASED ADHERENCE 
Treatment attendance and medication adherence among people with severe mental illness 
(SMI) has been shown to improve clinical outcomes, such as psychosocial functioning and 
reduced psychiatric symptoms (Kampman & Lehtinen, 1999). Unfortunately, up to 75% of 
consumers with SMI fail to adhere to prescribed regimens of medications within two years of 
discharge from a hospital (Olfson et al., 2000; Perkins, 1999) leading to increased risk of relapse, 
suicide, violence, and arrest (Fenton & Mc Glashan, 1994; Steadman et al., 2001; Young, Spitz, 
Hillbrand, & Daneri, 1999).  Studies have documented the economic burden of treatment 
nonadherence in SMI (Thieda, Beard, Richter, & Kane, 2003), with one estimate indicating that 
direct medical costs resulting from nonadherence in psychotic disorders are approximately $2.3 
billion per year (Olfson et al., 2000).  Yet, there is currently limited understanding of the 
psychological mechanisms underlying treatment attendance and adherence among people with 
SMI: Treatment motivation and working alliance could be key factors associated with 
persistence in psychosocial treatment and taking prescribed psychiatric medications. 
Testing the Predictive Validity of the WAI and TMQ 
In other medical populations, treatment motivation, specifically intrinsic motivation has 
been predictive of adherence to medicines (Ryan, Plant, & O'Malley, 1995; Williams & Deci, 
2001; Williams, Grow, Freedman, Ryan, & Deci, 1996; Williams, McGregor, Zeldman, 
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Freedman, & Deci, 2004; Williams, Rodin, Ryan, Grolnick, & Deci, 1998a, , 1998b). To date, 
there have been no studies looking at the predictive validity of the TMQ among people with 
severe mental illness. Similarly, there is a dearth of evidence illustrating the predictive validity of 
the WAI – Short form, even though one study found that a greater working alliance related to 
better treatment attendance (Dunn, Morrison, & Bentall, 2006; Neale & Rosenheck, 1995; 
Pyszczynski, Greenberg, & Solomon, 2000). Thus, the current study aims to test the ability of the 
WAI - Short form and the TMQ to predict treatment adherence among people with SMI. 
Treatment Adherence: What is it and why is it an important outcome? 
The majority of research on treatment adherence in SMI focuses on adherence to 
medication regimens specified by psychiatrists (Zygmunt, Olfson, Boyer, & Mechanic, 2002). 
Even though there are numerous interventions aimed at increasing motivation to adhere to 
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treatment (Zygmunt, Olfson, Boyer, & Mechanic, 2002), lack of motivation to take 
medication is still very high. The lack of adherence to medication in SMI ranges from 26 to 
58 percent (Cramer & Rosenheck, 1998). Studies have found that lack of medication 
adherence or motivation leads to at-risk behaviors such as violence, drug and alcohol abuse, 
and an increase in hospitalization, i.e., the revolving-door problem (Olfson et al., 2000; 
Swartz et al., 1998a; Swartz et al., 1998b). Due to the high rates of medication non-adherence 
among people with SMI, many intervention strategies focus primarily on medication 
compliance as an outcome (Adams & Scott, 2000b; Cramer & Rosenheck, 1998; Zygmunt, 
Olfson, Boyer, & Mechanic, 2002).  However, the term treatment adherence does not only 
refer to maintaining a psychotropic medication regimen, but also to participating in the array 
of mental health services available to people with SMI. 
Most clinicians recognize the importance of providing psychosocial treatment in 
conjunction with psychiatric medications (Lenroot, Bustillo, Lauriello, & Keith, 2003). 
Indeed, medication adherence alone does not guarantee a lessening of symptoms and 
improvement in quality of life. One study has shown that even among individuals adhering to 
treatment, relapse rates within one year of inpatient discharge were as high as 14 to 40 
percent (Lenroot, Bustillo, Lauriello, & Keith, 2003).  Consumers’ with medication 
adherence often continue to have symptoms and cognitive deficits even while they are taking 
medications (Liberman, 1994). Psychosocial treatments can aid consumers to manage these 
difficult symptoms and side-effects. Although there are biological and mental health system 
barriers to care, this paper will focus on the psychological mechanisms that lead to adherence 
to medications and psychosocial appointments.  
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Psychological Mechanisms 
Working alliance. 
Within psychosocial therapy, lack of treatment adherence can result from a poor 
working alliance with the therapist. Studies have found that adequate working alliances 
increase the consumers’ adherence because they feel that their treatment needs are 
understood and that they have some input into their treatment (Nageotte, Sullivan, Duan, & 
Camp, 1997; Olfson et al., 2000; Osterberg & Blaschke, 2005).  
Treatment motivation. 
The psychological mechanism of treatment motivation, defined in this paper as the 
reasons an individual stays in psychosocial treatment or continues to take medications (often 
termed treatment adherence), has limited research among people with SMI. Indeed, the 2003 
President’s New Freedom Commission Report on Mental Health calls for an increase in 
psychosocial approaches which “enhance motivation and address psychiatric stabilization, 
skills acquisition, and relapse prevention” (Ziedonis et al., 2005). Although there has been 
recent clinical research in this area, specifically, the adaptation of motivational interviewing 
to increase consumers’ adherence to psychiatric medication, there has been no evidence of 
the psychological mechanisms that could produce this change (Ogedegbe et al., 2007; A. J. 
Swanson, Pantalon, & Cohen, 1999). The current literature on treatment attendance and 
adherence has served as a behavioral proxy for treatment motivation under the assumption 
that people need motivation to attend and adhere to treatment. However, unless and until the 
research helps explain why an individual engages in treatment or what motivates an 
individual to engage in treatment, researchers and clinicians will be left with interventions 
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and behavioral outcomes without any knowledge of the motivational changes, (i.e. the 
psychological mechanism of change).  
External rewards effect intrinsically motivated behaviors. 
 In a ground-breaking study on the effects of external rewards on intrinsically 
motivated behavior, Deci found that college students who were not given external rewards to 
work on a puzzle worked on the task longer than those given external rewards, in this case 
money (Deci, 1971). In a meta-analysis of studies replicating Deci’s original findings, more 
than 125 articles were reviewed on the external reward of intrinsically motivated behaviors. 
The review found that external rewards undermine intrinsic motivation (Deci, Koestner, & 
Ryan, 1999). Indeed the meta-analysis found that engagement, completion, and performance 
contingencies undermined intrinsic motivation and the individual’s self-report of interest in 
the task at hand in both children and adults (Deci, Koestner, & Ryan, 1999).  
Unfortunately, how well SDT fits with SMI is largely unknown. Although some of 
the symptoms of the SMI spectrum of illnesses may prevent or diminish motivation to 
engage in enjoyable behaviors, the SDT findings of lessened intrinsic motivation due to 
external motivators may shed light on the efficacy of coercive treatments for people with 
SMI. The current study involves a naturalistic exploration of the relationship between 
treatment motivation and working alliance on adherence outcomes. Specifically, do the 
Working Alliance Inventory (WAI) and the Treatment Motivation Questionnaire (TMQ) have 
the ability to predict attendance of clinical meetings and medication adherence? If so, does 
the clinicians’ number of years of clinical experience moderate consumers’ intrinsic 
motivation to attend mental health treatment?  
Method 
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Sample selection. Data for this study come from the baseline and six month interview 
of a sample enrolled in a randomized study of the effectiveness of psychiatric advance 
directives (J. W. Swanson et al., 2006b).  See Chapters II and III for further information on 
selection criteria. 
Screening, informed consent, and recruitment.  Treating clinicians verified that 
identified patients met study criteria and sought patient permission to be contacted by a 
researcher.  Patients willing to be contacted were approached by a research interviewer.   
Measures 
 Treatment Motivation Questionnaire (TMQ). 
The original Treatment Motivation Questionnaire (TMQ) developed by Ryan and 
Deci (1985) was derived from Self-Determination Theory in order to measure treatment 
motivation. In the current research, the TMQ was adapted for the SMI population. A total of 
25 items were included in the new survey. Most items remained the same or were slightly 
changed. For example, the item, “It will be a relief for me to share my concerns with other 
program participants” was revised to read, “It will be a relief for me to share my concerns 
with others in treatment.” The TMQ response categories comprise a seven-point Likert scale, 
ranging from 1 (not at all true) to 7 (very true). The TMQ was administered at both the 
baseline and six month interview. 
 Working Alliance Inventory (WAI). 
Working alliance was assessed with the short form of the Working Alliance Inventory 
(WAI) adapted for use with SMI individuals and their mental health clinicians (Horvath & 
Greenberg, 1989; Neale & Rosenheck, 1995). Both the consumer and clinician forms of the 
WAI measure two domains. The WAI measures the degree to which the therapist and 
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consumer assess the bond and shared goals in their working relationship. The two scales for 
therapist and consumer share parallel forms. For example, under the shared goal subscale, the 
consumer is asked to rate the statement, “My clinician perceives accurately what my goals 
are;” the clinician is asked to rate the statement, “The client and I have a common perception 
of his/her goals.” The WAI response categories comprise a five-point Likert scale, ranging 
from 1 (strongly agree) to 5 (strongly disagree). Both versions of the scale were 
administered at baseline and six months. 
Treatment Adherence Composite. 
 The treatment adherence variable is a composite variable based on the experiences of 
the clinician and consumer dyad at the six month interview of the study. Each clinician was 
asked if the consumer he or she treats has had an appointment in the past six months; if the 
clinician answered affirmatively, he or she was asked about the consumer’s frequency of 
missed appointments. The Likert scale metric for this variable ranged from 1 (never missed 
appointments) to 5 (avoided all appointments). Likewise, the clinicians were also asked 
whether or not the consumers were being prescribed medicine and whether it was taken 
regularly, the Likert response scale ranged from 1 (never missed medications) to 6 (never 
took medications). The clinicians’ reports at six months were then compared with the 
consumers’ views of these same variables. Due to the binomial distributions of the adherence 
and attendance variables, the variables were collapsed. That is, if the consumer and clinician 
were in agreement about the client having never missed an appointment and never having 
missed medications, than the adherence variable was scored as a one. However, if either the 
consumer or case manager rated the attendance or adherence as otherwise, then the 
attendance variable was scored as zero.  
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Sample 
 Consumer Characteristics. 
See consumer sample description from Chapter III. 
Clinician Characteristics. 
See clinician sample description from Chapter III. 
 
 
Data Analysis 
Hierarchical logistic modeling (HLM) controlled for the consumers nested within 
clinicians by modeling the clinician variable as a random effect using an unstructured 
covariance structure (Raudenbush & Bryk, 2002). HLM analysis occurred in three steps. 
First, bivariates were used to test whether or not the consumer and clinician level covariates 
from baseline and the six month interview predict treatment adherence at six months 
individually.  Second, domain models were run in order to reduce potential redundancies and 
collinearity between variables. Lastly, variables that were significant in domain models were 
combined in order to produce a final model. Additionally, because the sample is from a study 
on the treatment effects of a psychiatric advanced directive (PAD), which had significant 
turnover in clinicians, the following analyses will control for PADs and change in clinician 
between the baseline and six month interview in the final model.  
Results 
 Overall, 19% of consumers and clinicians were in agreement that the consumer was 
attendant to meetings and adherent to medications at the six month interview of the study. Of 
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the adherent consumers, 79.45% were diagnosed with a schizophrenia spectrum disorder, 
about 18% with Bipolar disorder (17.81%), and only 3% percent with major depression with 
psychotic features (2.74%).  
Unconditional Model 
The estimated intercept in the unconditional HLM analysis that included only the 
random effects in the model is 0.27.  Because this HLM model includes only random effects, 
this is the log of the odds of a consumer adhering to mental health care in a typical or average 
clinician unit in the sample. The exponent of this log (exp b) equals -1.35. This exponent is 
the odds ratio (i.e., the probability of adhering to mental health care divided by the 
probability of not adhering to care) in a typical clinician unit. The odds ratio translates into 
an estimated probability of adhering to mental health care of .20 in a typical unit, which is 
slightly higher than the overall proportion of consumers in the sample who report adhering to 
mental health care (.19). This is a function of the difference between individual level and unit 
level rates of adherence to care. 
Predictors of Adherence 
 Bivariates. 
Table 4.1 illustrates the results of the bivariate relationships between consumer and 
clinician characteristics and treatment adherence. The consumer bivariate results indicate that 
the consumer version of the Working Alliance Bond subscale is predictive of treatment 
attendance and adherence at baseline but does not consistently predict for adherence at six 
months, even when controlling for a change in clinician during that time. In addition to this 
finding, baseline characteristics of being older than 42 and having a diagnosis of 
schizophrenia were significantly related to the likelihood of being adherent to mental health 
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services, whereas individuals with a diagnosis of bipolar disorder were less likely to adhere 
to mental health services. 
Of the clinician-level variables, clinicians with more years of experience were more 
likely to have adherent consumers than those of lesser experience. Also, the consumers’ 
working alliance bond at six months was significantly related to adherence, and there was a 
trend for clinicians who have a greater working alliance goal to be related to adherence. 
Table 4.1: Bivariate Hierarchical Logistic Models Predicting Consumer Treatment 
Adherence at 6 months   
Model                Variable Coefficient Odds Ratio (95% C.I.) SE T-ratio P 
Consumer Level Demographics        
 Gender (Male = 1) -0.08 0.92 (0.53 -1.59) 0.28 -0.30  
 Median Age (>42 years old) 0.82 2.27 (1.31 -3.94) 0.28 2.92 ** 
 Race (African American = 1) -0.04 0.96 (0.56 -1.65) 0.27 -0.16  
Consumer Level Clinical 
Variables        
 Diagnosis        
   Schizophrenia 1.17 3.22 (1.71 -6.03) 0.32 3.65 *** 
   Bipolar Disorder  -0.69 0.50 (0.25 -0.99) 0.34 -2.01 * 
 Substance Abuse -0.42 0.66 (0.23 -1.89) 0.53 -0.78  
 
Insight (Median ITAQ score 
>20) -0.18 0.84 (0.47 -1.48) 0.29 -0.62  
 Change in Case Manager  -0.32 0.73 (0.35 -1.50) 0.37 -0.87  
Consumer Level Experimental 
Intervention        
 
Facilitated Psychiatric 
Advanced Directive -0.26 0.77 (0.43 -1.37) 0.29 -0.89  
Consumer Level Psychological 
Mechanisms 
       
 Working Alliance Inventory        
   Bond Subscale (Baseline) 0.10 1.10 (1.00 -1.21) 0.05 2.04 * 
   Bond Subscale (Six Month) 0.04 1.04 (0.96 -1.13) 0.04 0.98  
   Goals Subscale (Baseline) 0.03 1.03 (0.95 -1.12) 0.04 0.74  
   Goals Subscale (Six Month) 0.03 1.03 (0.95 -1.12) 0.04 0.73  
 
Treatment Motivation 
Questionnaire         
   Intrinsic Subscale (Baseline) -0.01 0.99 (0.96 -1.03) 0.02 -0.55  
 
  Intrinsic Subscale (Six 
Month) 0.01 1.01 (0.98 -1.05) 0.02 0.70  
 
  Extrinsic Subscale 
(Baseline) -0.03 0.97 (0.93 -1.01) 0.02 -1.36  
 
  Extrinsic Subscale (Six 
Month) 0.01 1.01 (0.97 -1.05) 0.02 0.63  
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  Locus of Control Subscale 
(Baseline) -0.02 0.98 (0.95 -1.02) 0.02 -0.90  
 
  Locus of Control Subscale 
(Six Month) -0.02 0.98 (0.94 -1.02) 0.02 -1.16  
 
  Motivated by Guilt Subscale 
(Baseline) -0.02 0.98 (0.94 -1.02) 0.02 -1.20  
 
  Motivated by Guilt Subscale 
(Six Month) 0.02 1.02 (0.98 -1.05) 0.02 0.83  
 
  Relational Subscale 
(Baseline) -0.01 0.99 (0.96 -1.02) 0.01 -0.68  
 
  Relational Subscale (Six 
Month) 0.00 1.00 (0.98 -1.03) 0.01 0.16  
Case Manager Level Covariates        
 Gender (Male)1 -0.25 0.78 (0.36 -1.70) 0.40   
 Age -0.02 0.99 (0.97 -1.01) 0.01 -1.47  
 Years of Experience 0.04 1.04 (1.01 -1.08) 0.02 2.32 ** 
 Working Alliance Inventory        
   Bond Subscale (Baseline) 0.04 1.04 (0.88 -1.24) 0.09 0.47  
   Bond Subscale (Six Month) 0.10 1.10 (1.00 -1.21) 0.05 2.02 * 
   Goals Subscale (Baseline) -0.01 0.99 (0.69 -1.43) 0.18 -0.06  
   Goals Subscale (Six Month) 0.12 1.13 (0.99 -1.29) 0.07 1.81 ~ 
 
1Covariate would not converge - used logistic model for estimate     
 
~Trend at p < .10 
* Significant at p < .05 
** Significant at p < .01 
***Significant at p <.001     
 
Domains. 
 As shown in Table 4.2, the domain level models reveal that when controlling for 
diagnoses of schizophrenia and bipolar disorder (reference category is major depression with 
psychotic features), that a diagnosis of schizophrenia is significantly related to treatment 
adherence, meaning that individuals with a diagnosis of schizophrenia have twice the odds of 
adhering to treatment than individuals with bipolar or major depressive disorders. 
Additionally, there is a trend in the relationship between a greater rating of the Working 
Alliance Bond subscale at baseline and adherence to mental health treatment at 6 months. 
 
Table 4.2: Hierarchical Logistic Model of Domains Predicting Consumer Treatment Adherence 
at 6 months 
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Model Variable Coefficient Odds Ratio (95% C.I.) SE T-ratio p 
Consumer Level Variables        
 Diagnosis        
 
  Schizophrenia 2.10 8.19 (1.89 -35.47) 0.74 2.83 ** 
 
  Bipolar Disorder  1.21 3.35 (0.71 -15.84) 0.79 1.53  
 Working Alliance Inventory       
 
  Bond Subscale (Baseline) 0.09 1.10 (0.99 -1.22) 0.05 1.83 ~ 
 
  Bond Subscale (Six Month) 0.01 1.01 (0.92 -1.10) 0.05 0.12  
 
        
Case Manager Level Covariates        
 Working Alliance Inventory       
 
  Bond Subscale (Baseline) 0.10 1.10 (0.77 -1.57) 0.17 0.58  
 
  Bond Subscale (Six Month) 0.15 1.16 (0.84 -1.60) 0.15 0.97  
 
  Goals Subscale (Baseline) -0.17 0.84 (0.38 -1.87) 0.38 -0.45  
 
  Goals Subscale (Six Month) -0.19 0.83 (0.50 -1.36) 0.24 -0.80  
 
~Trend at p < .10 
* Significant at p < .05 
** Significant at p < .01 
***Significant at p <.001        
 
 Final Model. 
 As shown in Table 4.3, two consumer-level covariates are significant in the final 
model when controlling for PADs and a change in case manager. Consumers older than 42 
years of age have more than twice the odds of being adherent than younger consumers. Also, 
consumers with schizophrenia have three times the odds of being adherent to mental health 
treatment than individuals with major depression with psychotic features and bipolar 
disorder. Finally, there is a trend between clinicians with more mental health experience and 
adherence, although this is not significant. 
Table 4.3: Hierarchical Logistic Final Model Predicting Consumer Treatment Adherence at 6 months 
Model Variable Coefficient Odds Ratio (95% C.I.) SE T-ratio p 
Consumer Level Variables        
 Median Age (>42 years old) 0.81 2.25 (1.21 -4.19) 0.31 2.58 ** 
 Schizophrenia 1.11 3.04 (1.52 -6.09) 0.35 3.15 ** 
 Working Alliance Inventory        
   Bond Subscale (Baseline) 0.08 1.08 (0.97 -1.21) 0.06 1.42  
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 Change in Case Manager -0.34 0.71 (0.26 -1.96) 0.51 -0.66  
 
Psychiatric Advance 
Directive -0.36 0.70 (0.37 -1.31) 0.32 -1.13  
Case Manager Level Covariates        
 Years of Experience 0.04 1.04 (1.00 -1.08) 0.02 1.95 ~ 
 
~Trend at p < .10 
* Significant at p < .05 
** Significant at p < .01 
***Significant at p <.001        
 
 Lastly, in Table 4.4, the cross-level interaction or moderating effect of clinicians’ 
years of experience on consumers’ intrinsic motivation on predicting adherence was 
analyzed. The statistically significant cross-level interaction indicates that all things being 
equal, there is a joint effect between the incremental increase in case manager years of 
experience and consumers’ intrinsic motivation for treatment.  
Table 4.4: Cross-level Interaction between consumers’ intrinsic motivation and case managers’ years of experience 
Model Variable Coefficient Odds Ratio (95% C.I.) SE T-ratio p 
Cross-level Interaction        
 
Consumer Intrinsic 
Motivation for Treatment by 
Case Managers Years of 
Experience 0.001 1.037 (1.01 -1.06) 0.0003 2.86 ** 
 
~Trend at p < .10 
* Significant at p < .05 
** Significant at p < .01 
***Significant at p <.001        
 
Discussion 
 In general, previous research has shown that adherence to mental health treatment 
leads to better outcomes such as a decrease in symptoms and better global functioning. 
Adherence also reduces costs and hospitalizations in the mental health system. More 
importantly, adherence also reduces the risk of consumers becoming violent or being 
victimized. This study illustrates that consumers who are older than 42 and diagnosed with 
schizophrenia tend to be more adherent than others. Unfortunately, the current study does not 
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offer support that working alliance and treatment motivation alone lead to treatment 
adherence among persons with severe mental illness. However, the number of years a 
clinician has been in mental health treatment was found to moderate adherent behavior 
through consumers’ intrinsic motivation to attend treatment.  
 Although the consumers’ bond of the working alliance was predictive of adherence 
within the bivariate analyses, working alliance becomes non-significant when other variables 
are entered into the model. The results illustrate that other clinical diagnosis variables and 
illness course variables are more predictive of adherence than psychological and social 
variables like treatment motivation and working alliance alone. There could be numerous 
reasons for this lack of methodological and substantive findings. 
Methodologically, the lack of predictive validity may be in part due to the stringent 
operationalization of adherence in this study.  In essence, there may be measurement error 
because the adherence variable could be enabling the study to only predict the most adherent 
individuals. Indeed, varying levels of adherence may certainly aid in the prediction of 
different levels of adherence. However, the current study was limited by variables with 
binomial distributions which did not allow for such analyses. Additionally, the definition of 
adherence used in this study may be different from those identified from other studies that 
support the direct relationship between intrinsic motivation and adherence.Further work is 
needed to create a better measure of adherence and to then better evaluate the predictive 
validity of the TMQ and WAI in people with SMI. 
Substantively, working alliance and treatment motivation may not have a direct 
impact on adherence because taking into account the context of the relationship with the 
clinician is necessary in order to begin to understand the interplay between the relational 
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alliance and the consumers’ willingness to engage and maintain treatment attendance and 
adherence. Further, the complicated exchange between consumer and clinician around 
treatment decision making which leads to adherence or lack of adherence could be crucial to 
predicting adherence. Future studies need to investigate the relationship between working 
alliance and shared decision making in mental health care. However, the substantive findings 
may also be diffused by other elements of the mental health system. During the course of the 
study, a process of mental health reform North Carolina resulted in privatization of services, 
which altered the context, location, and providers of services for the majority of consumers 
within the study. Even if mental health care reform alone did not decrease the availability of 
services, changes in clinicians and their site locations may have (at least temporarily) reduced 
attendance for all but the most psychiatrically stable. 
 Indeed, beyond the confounding historical effect that may impact the result of this 
study, there may be factors that impact treatment attendance. Factors such as mental health 
symptoms may inhibit treatment attendance. For example, the negative and positive 
symptoms of schizophrenia may contribute significantly to the lack of adherence to 
treatment. Within negative symptoms, or “absence of normal functions” (Ananth et al., 
1991), there is the symptom of avolition -- the inability to initiate and persist in goal directed 
activities -- which interferes with motivation for treatment and daily life choices (Ananth et 
al., 1991).  Also, positive symptoms such as hallucinations, delusions, grandiosity, and 
paranoia also have been found to predict treatment non-adherence to medication and 
emergency psychosocial treatment (Mulder, Koopmans, & Hengeveld, 2005).  Other issues 
often associated with SMI are lack of insight and substance abuse. These issues are often 
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believed to be related to the lack of treatment adherence, although these variables were not 
significantly related to adherence in this study.  
However, the complexity of predicting adherence to medical and psychosocial 
treatment is not limited to the symptom manifestations and comorbidities of SMI; the 
treatment context is also important because mental health systems offer a broad range of 
services. Indeed, this study was not able to control for the types of services delivered to 
consumers. Future research may focus on treatment motivation and working alliance within 
specific services. For example, Assertive Community Treatment (ACT) may have individuals 
with greater external pressures attend care than those in usual outpatient care settings; the 
individuals, however, may also feel a greater working alliance with their clinicians because 
of the frequent contact of ACT clinical care. 
Limitations of these findings are that the outcomes are specific to overall care within 
a service system undergoing mental health reform. Due to this reform, adherence to services 
may be affected along with the turn over of clinicians within the system. Thus, although the 
study controlled for the change of clinician, there were no controls for changes in the mental 
health care system which may have affected subjects differently, depending on when they 
were enrolled.  
Further research is needed on the role of the mental health worker in the consumers’ 
adherence to mental health treatment. Specifically, qualitative studies should focus on the 
skills and tools performed and provided by clinicians with experience in the field in order to 
further discover the clinical skills that lead to adherence. The clinicians’ caseload size, 
productivity demands, and educational background may play an important role in the 
working alliance experienced by consumers. Also, the clinicians’ education may influence 
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their ability to have knowledge of or implement evidence based practices. Lack of 
effectiveness in clinical practice can result in worker burnout and discouragement which in 
turn sabotages a healthy working alliance. 
In closing, the findings support the notion that individuals with schizophrenia may be 
more adherent to mental health treatment due to psychiatric stabilization and recovery that 
comes with older age. Although the psychological mechanisms of motivation and working 
alliance were not directly predictive of treatment adherence within this study, the context of a 
clinicians years of experience combined with a consumers’ intrinsic motivation was related 
to an increase in treatment adherence among people with SMI. Future research on adherence 
and attendance to mental health services should include predictors of mental health 
symptoms, legal mandates, clinician characteristics and other Biopsychosocial factors related 
to mental health care.
   
 
CHAPTER 5 
 
CONCLUSIONS 
 
 Mental health professionals face the challenge of understanding and predicting 
psychosocial treatment attendance and medication adherence among adults with severe mental 
illness. This series of studies aimed to contribute to the knowledge base by validating measures 
for use in clinical practice and using those measures in order to predict mental health service 
adherence so that mental health service providers might better promote adult mental health.  
Validation of the Treatment Motivation Questionnaire 
The exploratory analysis in a confirmatory framework lends further support for the 
current conceptual framework of self-determination theory (SDT) and organismic integration 
theory (OIT).  Specifically, two sub-dimensions of external motivation (i.e., external and 
introjected) were uncovered within these analyses. Importantly, these results indicate that 
different types of external motivators are at work in motivating treatment participation by people 
with severe and persistent mental illness. Due to the use of external motivation in many of the 
treatments for this population, the TMQ may be helpful in assessing the impact that external 
motivation has on treatment adherence.  
The current analysis confirms the applicability of the SDT conceptual framework for 
understanding treatment adherence (or lack of adherence) among people with severe mental 
illness. Although the literature on treatment adherence among SMI individuals often highlights 
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the role of coercion and external motivators, little has been done to explore other types of 
self-determined regulators or motivations that may actually drive or inhibit treatment 
engagement in this population. Knowing more about the specific types of motivation that support 
long-term treatment adherence in these individuals would help clinicians in their efforts to 
engage patients in beneficial therapies.  
Confirming the Working Alliance Inventory -Short Form   
In this study, a truncated version of the WAI short form was tested within a sample of 
people with SMI and their clinicians. Our overall finding provides moderate support for the 
original factor structure and strong support for a higher-order model for this population. The 
excellent model fit for both consumer and clinician second order structure indicates that the two 
subscales of Bond and Goals in the working alliance relate to the larger construct of working 
alliance thus summing the subscales to create a total score can be done. Secondly, the internal 
reliability of the scales and subscales were excellent, which further supports the use of the 
subscales and the total score within this population. Finally, this study illustrates that the 
construct of working alliance for consumers and clinicians is not necessarily correlated if the 
duration of the working alliance does not support the time for this development. Overall, the 
WAI short form proves to be a reliable and brief scale that could easily be administered by 
clinicians in order to better monitor their practices.   
Predicting mental health treatment attendance and adherence   
  Overall, the current study failed to demonstrate a relationship between working alliance 
or treatment motivation and adherence. Although the bond of the working alliance was predictive 
of adherence within the bivariate analyses, there were other covariates that strongly predicted 
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treatment adherence. However, these findings may be affected by changes in the mental health 
care system in North Carolina which occurred during the course of the study.  
However, the complexity of predicting adherence to medical and psychosocial treatment 
is not limited to the context of the mental health system. Other biopsychosocial factors may 
impede treatment adherence such as symptom manifestations, comorbidities, the type of 
treatment, financial resources, and available transportation. The findings support the notion that 
individuals with schizophrenia may be more adherent to mental health treatment due to 
psychiatric stabilization and recovery that comes with older age.  
Limitations 
 There are several limitations to the current research. Specifically, the context of mental 
health care reform in the state of North Carolina during the time of data collection could have 
created uncontrollable historic effects. Additionally, psychological mechanisms to treatment 
adherence are difficult to interpret without the context of the known treatment type. Although the 
predictive validity of the truncated WAI short form was modestly related to treatment adherence, 
without a context of treatment type, the therapeutic behaviors associated with mechanism are 
largely unknown.  
 Additionally, there are limitations specific to each study. The TMQ validation study 
evaluates a scale that is in need of further scale development. Indeed, other subscales need to be 
created and tested within this population. The WAI short form used in this research is missing 
the Task subscale, and although this data confirms a portion of the scale, more work is needed to 
confirm the scale in its entirety. Lastly, due to unanticipated negative consequences of mental 
health care reform in the state of North Carolina, adherence to services may be negatively 
affected by additional barriers, such as turnover of clinicians within the system. 
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Future directions 
 The research highlights the need to learn more about psychological mechanisms to 
adherence among people with severe mental illness. Specifically, further scale development and 
validation is needed in the areas of treatment motivation and working alliance. The TMQ 
validation study used an exploratory factor analysis in a confirmatory framework. This method 
should not confuse future researchers, in that confirmatory work is still needed on this measure. 
However, before confirmatory work can be accomplished, development of questions relating to 
the sub-dimensions of external motivation (i.e., identified and integrated motivation) need to be 
developed and piloted within this population. Further, the WAI-short form also is in need of 
further validation in order to confirm the factor structure with the added Task scale and in order 
to evaluate whether the scale needs item reduction to decrease redundancies.  
Although the psychological mechanisms of motivation and working alliance were not 
predictive of treatment adherence within this study, future research should focus on exploring 
and measuring attitudes, motivations, and relational support that may lead to increased treatment 
adherence in SMI. Until research can better explain the reasons for adherence, efforts to increase 
adherence will fall short of successful outcomes. 
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APPENDICES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix I: TMQ Polychoric Correlations 
             
             
 1 2 3 5 6 7 9 10 11 12 13 14 
             
1 1            
2 0.15 1           
3 0.34 0.26 1          
5 0.26 0.42 0.27 1         
6 0.21 0.15 0.2 0.41 1        
7 0.13 0.26 0.23 0.65 0.54 1       
9 0.15 0.27 0.25 0.66 0.47 0.76 1      
10 -0.06 0.51 0.24 0.3 0.02 0.4 0.36 1     
11 0.32 0.04 0.29 0.24 0.34 0.11 0.22 -0.17 1    
12 0.12 -0.2 -0.01 0.05 0.17 0.02 0.05 -0.44 0.28 1   
13 -0.01 0.55 0.19 0.21 -0.08 0.25 0.12 0.64 -0.24 -0.35 1  
14 0.13 -0.13 -0.02 0.12 0.13 -0.02 0.12 -0.3 0.32 0.53 -0.32 1 
15 0.11 0.29 0.26 0.27 0.11 0.26 0.19 0.35 0.07 -0.15 0.43 -0.14 
16 0.09 0.34 0.18 0.18 0.05 0.17 0.1 0.47 0 -0.23 0.43 -0.21 
17 0.02 0.38 0.2 0.18 0.07 0.18 0.18 0.47 0 -0.23 0.41 -0.25 
18 0 0.34 0.06 0.21 -0.06 0.23 0.17 0.49 -0.21 -0.32 0.61 -0.2 
19 0.1 -0.13 0.02 0 0.03 -0.08 0.09 -0.32 0.21 0.56 -0.32 0.65 
20 0.08 0.3 0.19 0.21 0.08 0.17 0.13 0.4 -0.01 -0.27 0.43 -0.2 
21 0.01 0.51 0.17 0.24 -0.06 0.24 0.15 0.63 -0.13 -0.34 0.59 -0.31 
22 0.21 -0.18 -0.06 0.1 0.08 -0.02 0.11 -0.37 0.28 0.61 -0.36 0.71 
23 0.02 0.25 0.25 0.19 0.04 0.15 0.16 0.46 0.02 -0.27 0.37 -0.23 
24 0.02 0.38 0.12 0.32 0.13 0.34 0.31 0.48 -0.03 -0.23 0.46 -0.14 
25 -0.07 -0.22 -0.17 -0.15 -0.05 -0.2 -0.05 -0.56 0.05 0.56 -0.56 0.46 
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Appendix I: TMQ Polychoric correlations (continued) 
 15 16 17 18 19 20 21 22 23 24 25 
15 1           
16 0.77 1          
17 0.63 0.74 1         
18 0.28 0.35 0.47 1        
19 -0.2 -0.26 -0.37 -0.31 1       
20 0.68 0.7 0.62 0.35 -0.2 1      
21 0.46 0.57 0.56 0.6 -0.45 0.51 1     
22 -0.12 -0.19 -0.26 -0.27 0.75 -0.21 -0.44 1    
23 0.7 0.73 0.73 0.39 -0.3 0.78 0.48 -0.31 1   
24 0.44 0.47 0.6 0.46 -0.24 0.52 0.5 -0.22 0.61 1  
25 -0.42 -0.41 -0.39 -0.42 0.57 -0.4 -0.52 0.6 -0.45 -0.39 1 
 
 
Appendix II: Correlation Matrix of Clinician WAI       
Items a b c d e f g h 
(a) Have a common perception of the 
client's goals. 1        
(b) The current goals of the work are 
important to client. 0.625 1       
(c) Have established a good understanding 
of the kinds of changes that would be good 
for client. 0.778 0.512 1      
(d) Are working toward mutually agreed 
upon goals. 0.757 0.631 0.775 1     
(e) Feel confident in clinician's ability to 
help client. 0.624 0.504 0.659 0.67 1    
(f) The relationship is important to the 
client. 0.655 0.397 0.697 0.662 0.64 1   
(g) The client has trust in clinician. 0.671 0.442 0.728 0.711 0.619 0.849 1  
(h) Have established a strong working 
alliance and rapport. 0.709 0.463 0.745 0.741 0.65 0.834 0.889 1 
 
 
Appendix III: Correlation Matrix of Consumer WAI 
Items a b c d e f g h 
(a) Have a common 
perception of the 
client's goals. 1        
(b) The current 
goals of the work 
are important to 
client. 0.74 1       
(c) Have established 
a good 
understanding of the 
kinds of changes 
that would be good 
for client. 0.72 0.73 1      
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(d) Are working 
toward mutually 
agreed upon goals. 0.75 0.73 0.81 1     
(e) Feel confident in 
clinician's ability to 
help client. 0.73 0.78 0.78 0.76 1    
(f) The relationship 
is important to the 
client. 0.67 0.77 0.7 0.7 0.82 1   
(g) The client has 
trust in clinician. 0.67 0.69 0.71 0.68 0.8 0.85 1  
(h) Have established 
a strong working 
alliance and rapport. 0.74 0.7 0.75 0.68 0.84 0.81 0.82 1 
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